Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes

American Journal of Clinical Nutrition

Volumn 72, Issue 5, 2000, Pages 1142-1149

  Engelen, Wendy ^a   Manuel Y Keenoy, Begoña ^a   Vertommen, Jan ^a   De Leeuw, Ivo ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cardiovascular disease risk factors; LDL and VLDL peroxidation; Thiobarbituric acid reactive substances; Type 1 diabetes; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; E MED; LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 0033746084     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/72.5.1142     Document Type: Article

References (63)

1. Diabetes as an atherogenic factor
2. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study
3. Oxidized low density lipoproteins: A role in the pathogenesis of atherosclerosis in diabetes?
4. Role of modified lipoproteins in diabetic macroangiopathy
5. The role of oxidized lipoproteins in atherogenesis
6. Vitamin E and other lipophilic antioxidants protect LDL against oxidation
7. Effect of dietary antioxidant combinations in humans: Protection of LDL by vitamin E, but not by β-carotene
8. Lipid peroxidation and diabetic complications: Effect of antioxidant vitamins C and E
9. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology
10. Vitamin E consumption and the risk of coronary heart disease in men
11. Vitamin E consumption and the risk of coronary heart disease in women
12. Vitamin E in plasma and platelets of human diabetic patients and control subjects
13. Production of 12-hydroxyeicosatetraenoic acid and vitamin E status in platelets from type 1 human diabetic subjects
14. Plasma retinol and alpha-tocopherol concentrations in insulin-dependent diabetes mellitus: Their relationship to microvascular complications
15. Relationship of blood thromboxane-B2 (TxB2) with lipid peroxides and effect of vitamin E and placebo supplementation on TxB2 and lipid peroxide concentrations in type 1 diabetic patients
16. Vitamin E and cardiovascular protection in diabetes
17. Dietary and pharmacologic regimens to reduce lipid peroxidation in non-insulin-dependent diabetes mellitus
18. Effect of α-tocopherol on LDL oxidation and glycation: In vitro and in vivo studies
19. The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients
20. The effect of modest vitamin E supplementation on blood glycated hemoglobin and triacylglycerol levels and red blood cell indices in type 1 diabetic patients
21. RRR-α-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus
22. Vitamin E reduction of protein glycosylation in diabetes. New prospects for prevention of diabetic complications
23. Pharmacological doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients
24. α-Tocopherol, an affective inhibitor of platelet adhesion
25. Platelet function in type I diabetes: Effects of supplementation with large doses of vitamin E
26. Effect of vitamin E supplementation on platelet thromboxane A2 production in type 1 diabetic patients. Double blind crossover trial
27. Prevention of platelet dysfunction by vitamin E in diabetic atherosclerosis
28. Antioxidant and triacylglycerol-lowering effects of vitamin E associated with the prevention of abnormalities on the reactivity and morphology of aorta from streptozotocin-diabetic rats
29. Lipoprotein oxidation: Mechanistic aspects, methodological approaches and clinical relevance
30. Safety of oral intake of vitamin E
31. Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults
32. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults
33. Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge
34. Determination of α-tocopherol in plasma, platelets and erythrocytes of type I and II diabetic patients by HPLC
35. A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalysed oxidation
36. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans
37. RRR- and SRR-α-tocopherols are secreted without discrimination in human chylomicrons, but RRR-α-tocopherol is preferentially secreted in very low density lipoproteins
38. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy
39. The measurement of nanograms of tocopherol from needle aspiration biopsies of adipose tissue: Normal and abetalipoproteinemic subjects
40. Kinetics of tissue α-tocopherol uptake and depletion following administration of high levels of vitamin E
41. Plasma tocopherol concentrations in response to supplemental vitamin E
42. Insulin decreases circulating vitamin E levels in humans
43. The role of α-tocopherol as a peroxyl radical scavenger in human low density lipoprotein
44. Vitamin E content and low density lipoprotein oxidizability induced by free radicals
45. Contributions of an in vivo oxidized LDL to LDL oxidation and its association with dense LDL subpopulations
46. Lipid and lipoprotein modification by advanced glycosylation end-products: Role in atherosclerosis
47. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose
48. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification
49. Oxidation resistance, oxidation rate, and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: Studies in vitamin E deficient subjects
50. Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol-10 and polyunsaturated fatty acid content
51. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation
52. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does a-tocopherol
53. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and α-tocopherol content
54. Antioxidant defenses and lipid peroxidation in human plasma
55. Free and albumin-bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation
56. Increase in circulating products of lipid peroxidation in smokers with IDDM
57. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in typed diabetic patients
58. Copper-induced lipid peroxidation in liposomes, micelles, and LDL: Which is the role of vitamin E?
59. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation
60. What dose of vitamin E is required to reduce susceptibility of LDL to oxidation?
61. The effect of α-tocopherol supplementation on LDL oxidation. A dose-response study